These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 33289579)
1. Development and evaluation of puerarin-loaded controlled release nanostructured lipid carries by central composite design. Ye Q; Li J; Li T; Ruan J; Wang H; Wang F; Zhang X Drug Dev Ind Pharm; 2021 Jan; 47(1):113-125. PubMed ID: 33289579 [TBL] [Abstract][Full Text] [Related]
2. Design and evaluation of nanostructured lipid carriers loaded with Salvia officinalis extract for Alzheimer's disease treatment. Markova E; Taneska L; Kostovska M; Shalabalija D; Mihailova L; Glavas Dodov M; Makreski P; Geskovski N; Petrushevska M; N Taravari A; Simonoska Crcarevska M J Biomed Mater Res B Appl Biomater; 2022 Jun; 110(6):1368-1390. PubMed ID: 35019231 [TBL] [Abstract][Full Text] [Related]
3. Design and characterization of Amoitone B-loaded nanostructured lipid carriers for controlled drug release. Luan J; Zhang D; Hao L; Li C; Qi L; Guo H; Liu X; Zhang Q Drug Deliv; 2013 Nov; 20(8):324-30. PubMed ID: 24032657 [TBL] [Abstract][Full Text] [Related]
4. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery. Gonzalez-Mira E; Egea MA; Souto EB; Calpena AC; García ML Nanotechnology; 2011 Jan; 22(4):045101. PubMed ID: 21169662 [TBL] [Abstract][Full Text] [Related]
5. Effect of Lipid and Oil Compositions on Physicochemical Properties and Photoprotection of Octyl Methoxycinnamate-loaded Nanostructured Lipid Carriers (NLC). Teeranachaideekul V; Morakul B; Boonme P; Pornputtapitak W; Junyaprasert V J Oleo Sci; 2020; 69(12):1627-1639. PubMed ID: 33268665 [TBL] [Abstract][Full Text] [Related]
6. Preparation, optimization and characteristic of huperzine a loaded nanostructured lipid carriers. Yang CR; Zhao XL; Hu HY; Li KX; Sun X; Li L; Chen DW Chem Pharm Bull (Tokyo); 2010 May; 58(5):656-61. PubMed ID: 20460792 [TBL] [Abstract][Full Text] [Related]
7. Systematic implementation of quality-by-design (QbD) to develop NSAID-loaded nanostructured lipid carriers for ocular application: preformulation screening studies and statistical hybrid-design for optimization of variables. Rathod VR; Shah DA; Dave RH Drug Dev Ind Pharm; 2020 Mar; 46(3):443-455. PubMed ID: 32037896 [TBL] [Abstract][Full Text] [Related]
8. Formulation, Characterization, and Pharmacokinetic Studies of 6-Gingerol-Loaded Nanostructured Lipid Carriers. Wei Q; Yang Q; Wang Q; Sun C; Zhu Y; Niu Y; Yu J; Xu X AAPS PharmSciTech; 2018 Nov; 19(8):3661-3669. PubMed ID: 30324361 [TBL] [Abstract][Full Text] [Related]
9. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Das S; Ng WK; Tan RB Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358 [TBL] [Abstract][Full Text] [Related]
10. Preparation, characterization, and Saghafi Z; Mohammadi M; Mahboobian MM; Derakhshandeh K Drug Dev Ind Pharm; 2021 Mar; 47(3):509-520. PubMed ID: 33650445 [TBL] [Abstract][Full Text] [Related]
11. Long chain lipid based tamoxifen NLC. Part I: preformulation studies, formulation development and physicochemical characterization. Shete H; Patravale V Int J Pharm; 2013 Sep; 454(1):573-83. PubMed ID: 23535345 [TBL] [Abstract][Full Text] [Related]
13. Design, characterization, and in vitro cellular inhibition and uptake of optimized genistein-loaded NLC for the prevention of posterior capsular opacification using response surface methodology. Zhang W; Li X; Ye T; Chen F; Sun X; Kong J; Yang X; Pan W; Li S Int J Pharm; 2013 Sep; 454(1):354-66. PubMed ID: 23876384 [TBL] [Abstract][Full Text] [Related]
14. Development of A Nanostructured Lipid Carrier-Based Drug Delivery Strategy for Apigenin: Experimental Design Based on CCD-RSM and Evaluation against NSCLC In Vitro. Wang X; Liu J; Ma Y; Cui X; Chen C; Zhu G; Sun Y; Tong L Molecules; 2023 Sep; 28(18):. PubMed ID: 37764446 [TBL] [Abstract][Full Text] [Related]
15. A Full Factorial Design to Optimize Aminexil Nano Lipid Formulation to Improve Skin Permeation and Efficacy Against Alopecia. Makky AMA; S El-Leithy E; Hussein DG; Khattab A AAPS PharmSciTech; 2023 Jan; 24(1):40. PubMed ID: 36653508 [TBL] [Abstract][Full Text] [Related]
16. [Preparation and characterization of oxaliplatin-loaded nanostructured lipid carriers]. Zhou H; Qiu LP; Yan XX; Li L; Li X; Wang L; Liu M; Wang DK Yao Xue Xue Bao; 2010 Sep; 45(9):1177-82. PubMed ID: 21351576 [TBL] [Abstract][Full Text] [Related]
17. Quality by design (QbD) optimization of diazepam-loaded nanostructured lipid carriers (NLC) for nose-to-brain delivery: Toxicological effect of surface charge on human neuronal cells. Costa CP; Cunha S; Moreira JN; Silva R; Gil-Martins E; Silva V; Azevedo L; Peixoto AF; Sousa Lobo JM; Silva AC Int J Pharm; 2021 Sep; 607():120933. PubMed ID: 34324988 [TBL] [Abstract][Full Text] [Related]
18. Improved pharmacokinetics and antihyperlipidemic efficacy of rosuvastatin-loaded nanostructured lipid carriers. Rizwanullah M; Amin S; Ahmad J J Drug Target; 2017 Jan; 25(1):58-74. PubMed ID: 27186665 [TBL] [Abstract][Full Text] [Related]
19. Lactoferrin-loaded nanostructured lipid carriers (NLCs) as a new formulation for optimized ocular drug delivery. Varela-Fernández R; García-Otero X; Díaz-Tomé V; Regueiro U; López-López M; González-Barcia M; Isabel Lema M; Javier Otero-Espinar F Eur J Pharm Biopharm; 2022 Mar; 172():144-156. PubMed ID: 35183717 [TBL] [Abstract][Full Text] [Related]
20. Quetiapine Fumarate Loaded Nanostructured Lipid Carrier for Enhancing Oral Bioavailability: Design, Development and Pharmacokinetic Assessment. Agarwal S; HariKumar SL; Negi P; Upadhyay N; Garg R Curr Drug Deliv; 2021; 18(2):184-198. PubMed ID: 32723273 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]